Outcomes
- 01
biomarker-hematology-bone-marrow-mast-cell-burden-reduction-greater-than-50-percent-rate
1 evidence row
- 02
biomarker-tryptase-serum-reduction-greater-than-50-percent-rate
1 evidence row
- 03
gastrointestinal-symptoms-resolution
1 evidence row
- 04
oncology-complete-remission-rate
1 evidence row
- 05
oncology-successful-osimertinib-tolerance-after-desensitization
1 evidence row